Clinical Trial Update: Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating haploidentical stem cell transplantation with IL-15 NK cell infusion for pediatric refractory solid tumors; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Haploidentical stem cell transplantation
• Interleukin-15 (interleukin-15)
• Natural killer cell infusion

Snippet

Sponsor: Hospital Infantil Universitario Niño Jesús, Madrid, Spain | Conditions: Childhood Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED